Cephalexin (Keflex) Safety During Lactation
Yes, cephalexin is safe for lactating women and breastfeeding can continue without interruption.
Evidence from FDA Drug Label
The FDA label for cephalexin explicitly addresses lactation, stating that "the excretion of cephalexin in human milk increased up to 4 hours after a 500 mg dose; the drug reached a maximum level of 4 mcg/mL, then decreased gradually, and had disappeared 8 hours after administration" 1. The label advises that "caution should be exercised when cephalexin is administered to a nursing woman," but this represents standard regulatory language rather than a contraindication 1.
Guideline Recommendations
Short courses of antibiotics, including cephalosporins like cephalexin, are commonly used peri-operatively and there is no evidence of harmful effects in breastfeeding women 2. The 2020 Association of Anaesthetists guideline specifically states that antibiotics are compatible with breastfeeding and directs clinicians to consult LactMed for detailed information 2.
Infant Exposure and Safety Profile
Minimal Infant Exposure
- Peak milk concentrations of cephalexin after a 1g oral dose average only 0.50 ± 0.23 mcg/mL at 4 hours, which represents extremely low levels 3.
- The relative infant dose (RID) is approximately 0.5% of the maternal weight-adjusted dose, well below the theoretical 10% threshold of concern 4.
- The absolute infant dose is calculated at only 112 mcg/kg/day 4.
Clinical Safety Data
- A systematic assessment of antibiotic lactation studies found that breastfed infants are exposed to subtherapeutic concentrations of cephalosporins 5.
- Cephalosporins as a class show infant exposure ranging from 13-38% when calculated via milk:plasma ratio, with cephalexin at the lower end 5.
- A prospective study of cephalexin use during lactation (n=11 control group) found an adverse effect rate of only 9%, with no serious events requiring cessation of breastfeeding 6.
Potential Adverse Effects
Gastrointestinal Effects
The most commonly reported adverse effect is mild diarrhea in the infant, which is typically self-limiting 4, 7.
- One case report documented an infant who developed diarrhea while the mother was taking cephalexin plus probenecid, with the Naranjo probability scale rating cephalexin as "probable" cause 4.
- However, this occurred with concomitant probenecid use, which may have increased cephalexin levels 4.
- Clinicians should anticipate the possibility of minor gastrointestinal effects but these do not necessitate interruption of breastfeeding 6.
No Systemic Toxicity
- No serious adverse effects, allergic reactions, or systemic toxicity have been reported in breastfed infants exposed to cephalexin 6.
- The low oral bioavailability of cephalosporins further limits infant systemic absorption 5.
Clinical Recommendations
Prescribing Approach
- Cephalexin can be prescribed to lactating women without requiring interruption of breastfeeding 2, 7.
- Most antibiotics, including penicillins, cephalosporins, and macrolides at standard dosages, are considered appropriate for lactating women 7.
- The 2020 guideline emphasizes that breastfeeding should be interrupted only when a drug might be harmful to the infant and exposure via breast milk poses a genuine risk 2.
Monitoring
- Advise mothers to observe infants for signs of loose stools or mild diarrhea 4.
- If gastrointestinal symptoms occur, they are typically mild and self-resolving 6.
- No special timing of doses relative to feeding is required given the low milk levels 3.
Important Caveats
Microbiome Considerations
While cephalexin is safe from a toxicity standpoint, emerging research suggests that even subtherapeutic antibiotic exposure may affect the developing infant microbiome 5. However, this theoretical concern must be balanced against the maternal need for appropriate infection treatment.
Alternative Antibiotics
When multiple safe options exist, amoxicillin remains a first-line choice with extensive safety data 7, 6. However, cephalexin represents an entirely appropriate alternative, particularly during amoxicillin shortages or when broader coverage is needed 8.